Global Cryoablation Devices Market Market Size
Cryoablation Devices Market is expected to increase at a 13.7% CAGR to reach US$ 1243.6 million by 2034, from its estimated US$ 345.6 million valuation in 2024.
During a cryoablation treatment, aberrant tissue is frozen and destroyed using liquid and a cryoprobe—a very cold tool. Compressed argon gas, liquid nitrogen, and liquid nitrous oxide are some of the materials used to chill these cryoprobes. The cryoablation process can be used to treat certain cancers and diseases that may lead to cancer.
One of the main factors propelling the global market's growth is the rising prevalence of cardiac arrhythmia, neurological disorders, and cancer. The target market is expanding due to the increased demand for minimally invasive procedures and the availability of customized probes for cryoablation. The global cryoablation devices market is anticipated to rise over the forecast due to an increase in the number of physicians using these devices all it.
Furthermore, a factor anticipated to fuel the growth of the worldwide cryoablation devices market over the forecast period is the requirement for relatively short hospital stays and quick recovery times for patients undergoing cryoablation procedures. However, one of the main obstacles to the target market is that the cryoablation device technique causes odd sensations in the affected tissues, like skin irritation, tingling, and numbness.
For example, the findings of previous and ongoing trials using cryoablation to cure stage I low-grade breast cancer are encouraging, showing a 98% overall clinical success rate and recurrence rates that are similar with what is predicted after lumpectomy. This demonstrates the effectiveness of cryoablation treatment in treating cancer, which will increase demand for cryoablation devices.